$3.17
0.01[0.32%]
At close: May 20
$3.17
0[0.00%]
After Hours: 4:38PM EDT
Cellectar Biosciences
(NASDAQ:CLRB)Cellectar Biosciences Stock (NASDAQ:CLRB), Analyst Ratings, Price Targets, Predictions
Cellectar Biosciences Inc has a consensus price target of $14.67, established from looking at the 5 latest analyst ratings. The last 3 analyst ratings were released from Roth MKM, Oppenheimer, and Roth MKM on March 28, 2024, March 28, 2024, and March 4, 2024. With an average price target of $20 between Roth MKM, Oppenheimer, and Roth MKM, there's an implied 530.91% upside for Cellectar Biosciences Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Roth MKM
Oppenheimer
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Cellectar Biosciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/28/2024 | Buy Now | 783.28% | Roth MKM | Jonathan Aschoff | $20 → $28 | Maintains | Buy | Get Alert |
| 03/28/2024 | Buy Now | 278.55% | Oppenheimer | Jeff Jones | $11 → $12 | Reiterates | Outperform → Outperform | Get Alert |
| 03/04/2024 | Buy Now | 530.91% | Roth MKM | Jonathan Aschoff | → $20 | Reiterates | Buy → Buy | Get Alert |
| 11/04/2022 | Buy Now | 26.18% | HC Wainwright & Co. | Swayampakula Ramakanth | $3 → $4 | Maintains | Buy | Get Alert |
| 07/18/2022 | Buy Now | 73.5% | Oppenheimer | Jeff Jones | → $55 | Assumes | → Outperform | Get Alert |
FAQ
What is the target price for Cellectar Biosciences (CLRB)?
The latest price target for Cellectar Biosciences (NASDAQ: CLRB) was reported by Roth MKM on March 28, 2024. The analyst firm set a price target for $28.00 expecting CLRB to rise to within 12 months (a possible 783.28% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cellectar Biosciences (CLRB)?
The latest analyst rating for Cellectar Biosciences (NASDAQ: CLRB) was provided by Roth MKM, and Cellectar Biosciences maintained their buy rating.
When was the last upgrade for Cellectar Biosciences (CLRB)?
There is no last upgrade for Cellectar Biosciences.
When was the last downgrade for Cellectar Biosciences (CLRB)?
There is no last downgrade for Cellectar Biosciences.
When is the next analyst rating going to be posted or updated for Cellectar Biosciences (CLRB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cellectar Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cellectar Biosciences was filed on March 28, 2024 so you should expect the next rating to be made available sometime around March 28, 2025.
Is the Analyst Rating Cellectar Biosciences (CLRB) correct?
While ratings are subjective and will change, the latest Cellectar Biosciences (CLRB) rating was a maintained with a price target of $20.00 to $28.00. The current price Cellectar Biosciences (CLRB) is trading at is $3.17, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.